Concepedia

Peter Chua

PC

Statistics

Publications

14

Citations

1.4K

H-Index

13

Active since

1997

Affiliations

Université de Montréal(Current)

General Atomics (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Peter Chua is an author at Université de Montréal specializing in medicinal chemistry, pharmacology, and organic synthesis.

Publications per year

1997–2013

14

Publications

14

CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

Adam Siddiqui-Jain, Denis Drygin, Nicole Streiner et al. · Cancer Research · 2010 · 513 citations

, , +16

Discovery and SAR of 5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer

Fabrice Pierre, Peter Chua, Sean O’Brien et al. · Journal of Medicinal Chemistry · 2010 · 299 citations · Full text

, , +15

Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer

Fabrice Pierre, Peter Chua, Sean O’Brien et al. · Molecular and Cellular Biochemistry · 2011 · 155 citations

, , +4

Total Synthesis of (−)-Sarain A

Michael Becker, Peter Chua, Robert Downham et al. · Journal of the American Chemical Society · 2007 · 110 citations

, , +17

Mild Method for the Synthesis of Thiazolines from Secondary and Tertiary Amides

André B. Charette, Peter Chua · The Journal of Organic Chemistry · 1998 · 88 citations

, , +8

1–5 of 14